Hint mode is switched on Switch off
For swift navigation between sections

Sanofi Bonds, 1.875% 21mar2038, EUR (34) (FIGI RegS BBG00K9ZVVS5, FR0013324373, WKN A19X5N)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard

PDF download

Choose all Reset all
Download Cancel

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access

Domestic bonds, Senior Unsecured

Issue | Issuer
Issuer
  • M
    ***   | ***
    ***
  • S&P
    ***   | ***
    ***
  • F
    ***   | ***
    ***
Status
Outstanding
Amount
1,250,000,000 EUR
Placement
***
Redemption (put/call option)
*** (-)
ACI
Country of risk
France
Current coupon
***%
Price
Yield / Duration
  • Placement amount
    1,250,000,000 EUR
  • Outstanding amount
    1,250,000,000 EUR
  • USD equivalent
    1,456,487,500 USD
  • Face value
    100,000 EUR
  • ISIN RegS
    FR0013324373
  • Common Code RegS
    179540428
  • CFI RegS
    DTFUFB
  • FIGI RegS
    BBG00K9ZVVS5
  • Ticker
    SANFP 1.875 03/21/38 20FX
Cbonds API

Get Financial Data Automatically via API

Receive pricing and descriptive data for

  • Bonds
  • Stocks
  • Indices
  • ETFs
  • Funds
  • Global data coverage: Descriptive data, Prices, cash flow, bond prospectuses, IFRS reports
  • Easy Integration: API • Data Feeds • Web Services
  • Transparent Pricing: Tailored to your needs
Free Plan

Start exploring global markets in less than 1 minute

  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds
  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Free Plan
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Files

Final Terms

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
No more than two exchanges can be selected for comparison at the same time
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issue information

Profile
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, ...
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Companys major shareholder was Loreal with a stake of 8.82%.
Show more Hide
Research report by Cbonds-PRAAMS Save
Authorization required
Report download is available only paid Premium subscription access
Volume
  • Placement amount
    1,250,000,000 EUR
  • Outstanding amount
    1,250,000,000 EUR
  • Outstanding face value amount
    1,250,000,000 EUR
  • USD equivalent
    1,456,487,500 USD
Face value
  • Face value
    100,000 EUR
  • Outstanding face value
    *** EUR
  • Increment
    *** EUR

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** EUR
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Use of proceeds
    General Corporate Purposes
    Acquisition Financing
  • Use of proceeds description
    The net proceeds of the issue of the Notes will be used for the general corporate purposes of the Issuer, including the financing of the acquisitions of Bioverativ and Ablynx
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***, ***, ***, ***
  • Depository
    ***
  • Arranger Legal Adviser (International law)
    ***

Conversion and exchange

  • Conversion terms
    ***

Issue is included in calculation of indices

Cbonds France Corporate EUR Duration Index
Cbonds France Corporate EUR G-spread Index
Cbonds France Corporate EUR Index
Cbonds France Corporate EUR Price Index
Cbonds France Corporate EUR T-spread Index
Cbonds France Corporate EUR YTM Index
Show more Hide

Latest issues

Show all

Similar issues

News

26/08/2026 Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity?
14/08/2026 6 Undervalued Stocks That Crushed Earnings
30/07/2026 Sanofi Beats on Q2 Earnings & Sales, Stock Down on Pipeline Setbacks
30/07/2026 Sanofi (NASDAQ: SNY) Prepares for Q2 2026 Earnings Report Amidst Strategic Shifts
29/07/2026 The Smartest Dividend Stock to Buy With $1,000 Right Now (Spoiler: It Yields 5.6%.)
All organization news

IFRS/US GAAP reports

2026
II q eng
2025
II q eng
IV q eng
2024
II q eng
IV q eng
2023
II q eng
IV q eng
2022
II q eng
IV q eng
2021
II q eng
IV q eng
2020
II q eng
IV q eng
2019
II q eng
IV q eng
2018
II q eng
IV q eng
2017
IV q eng
Show more Hide
Authorization required
You need to request access

Identifiers

  • ISIN RegS
    FR0013324373
  • Cbonds ID
    418425
  • Common Code RegS
    179540428
  • CFI RegS
    DTFUFB
  • FIGI RegS
    BBG00K9ZVVS5
  • WKN RegS
    A19X5N
  • Ticker
    SANFP 1.875 03/21/38 20FX
  • Type of security by CBR
    ***

Ratings

Bond classification

  • Senior Unsecured
  • Coupon bonds
  • Bearer
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Non-complex financial instruments (MiFID)
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Holders

Registration is required to get access.